StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pacira Pharma (PCRX) Doesn't Win FDA Panel Backing of EXPAREL in 6 to 4 Vote Against Approval
February 15, 2018 3:01 PM
Pacira Pharma (NASDAQ: PCRX) doesn't ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Hot FDA News
Trading Halts
Next Articles
Needham & Company Downgrades Pacira Pharmaceuticals (PCRX) to Hold
February 16, 2018 7:20 AM
Pacira Pharmaceuticals (PCRX) PT Lowered to $32 at BMO Capital
February 16, 2018 6:11 AM
Pacira Pharma (PCRX) to Resume Trading at 4:15 pm ET
February 15, 2018 3:51 PM
Pacira Pharma (PCRX) Confirms Only Four FDA Committee Members Voted to Recommend Approval of EXPAREL sNDA
February 15, 2018 3:36 PM
Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
February 14, 2018 1:29 PM
Pacira Pharma (PCRX) Confims Trading Halt Ahead of FDA AdCom
February 14, 2018 1:29 PM
